SI1558610T1 - Substituirane aminokinuklidinske spojine in njihova uporaba kot ligandi delta-opioidnega receptorja - Google Patents

Substituirane aminokinuklidinske spojine in njihova uporaba kot ligandi delta-opioidnega receptorja

Info

Publication number
SI1558610T1
SI1558610T1 SI200331191T SI200331191T SI1558610T1 SI 1558610 T1 SI1558610 T1 SI 1558610T1 SI 200331191 T SI200331191 T SI 200331191T SI 200331191 T SI200331191 T SI 200331191T SI 1558610 T1 SI1558610 T1 SI 1558610T1
Authority
SI
Slovenia
Prior art keywords
delta
opioid receptor
agents
receptor ligands
useful
Prior art date
Application number
SI200331191T
Other languages
English (en)
Inventor
Robert E Boyd
Allen B Reitz
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SI1558610T1 publication Critical patent/SI1558610T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
SI200331191T 2002-10-15 2003-10-14 Substituirane aminokinuklidinske spojine in njihova uporaba kot ligandi delta-opioidnega receptorja SI1558610T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41860302P 2002-10-15 2002-10-15
EP03776299A EP1558610B1 (en) 2002-10-15 2003-10-14 Substituted aminoquinuclidine compounds and their use as delta-opioid receptor ligands
PCT/US2003/032221 WO2004035574A2 (en) 2002-10-15 2003-10-14 Substituted aminoquinuclidine compounds and their use as delta-opioid receptor ligands

Publications (1)

Publication Number Publication Date
SI1558610T1 true SI1558610T1 (sl) 2008-08-31

Family

ID=32107953

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331191T SI1558610T1 (sl) 2002-10-15 2003-10-14 Substituirane aminokinuklidinske spojine in njihova uporaba kot ligandi delta-opioidnega receptorja

Country Status (13)

Country Link
US (1) US7179818B2 (sl)
EP (1) EP1558610B1 (sl)
JP (1) JP2006504754A (sl)
AT (1) ATE387443T1 (sl)
AU (1) AU2003284068A1 (sl)
CA (1) CA2501552A1 (sl)
CY (1) CY1107928T1 (sl)
DE (1) DE60319405T2 (sl)
DK (1) DK1558610T3 (sl)
ES (1) ES2300626T3 (sl)
PT (1) PT1558610E (sl)
SI (1) SI1558610T1 (sl)
WO (1) WO2004035574A2 (sl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1638560A1 (en) * 2003-06-20 2006-03-29 Eli Lilly And Company 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake
NZ546834A (en) 2003-10-01 2010-03-26 Adolor Corp Spirocyclic heterocyclic derivatives and methods of their use
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9811842B (en) * 1997-12-24 2000-06-23 Ortho Mcneil Pharm Inc 4-[aryl(piperidin-4-yl)]aminobenzamides.
US6306876B1 (en) 1999-12-22 2001-10-23 Ortho-Mcneil Pharmaceutical, Inc. 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives

Also Published As

Publication number Publication date
DK1558610T3 (da) 2008-06-23
CA2501552A1 (en) 2004-04-29
DE60319405D1 (de) 2008-04-10
US7179818B2 (en) 2007-02-20
JP2006504754A (ja) 2006-02-09
EP1558610B1 (en) 2008-02-27
AU2003284068A1 (en) 2004-05-04
US20040110789A1 (en) 2004-06-10
CY1107928T1 (el) 2013-09-04
DE60319405T2 (de) 2009-02-26
PT1558610E (pt) 2008-04-18
WO2004035574A3 (en) 2004-06-03
ATE387443T1 (de) 2008-03-15
WO2004035574A8 (en) 2004-07-29
ES2300626T3 (es) 2008-06-16
AU2003284068A8 (en) 2004-05-04
WO2004035574A2 (en) 2004-04-29
EP1558610A2 (en) 2005-08-03

Similar Documents

Publication Publication Date Title
WO2001066543A3 (en) 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
HK1080466A1 (zh) 用於治療過度增生疾病的稠合三環雜環
HK1071890A1 (en) Spiroazacyclic compounds as monoamine receptor modulators
MXPA06001647A (es) 6-(2, 2, 2-trifluoroetilamino) -7-cloro-2, 3, 4, 5-tetrahidro- 1h-benzo[d] azepina como un agonista del receptor 5-ht2c.
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
IL148071A0 (en) Method for treatment of symptoms of central nervous system disorders
TW200504034A (en) Therapeutic agents
MXPA03012013A (es) Derivados de 1-oxa-2,8-diaza-spiro[4,5]dec-2-eno sustituidos como medicamento para el tratamiento de dolor.
GB0329498D0 (en) Organic compounds
NO20015413D0 (no) Anvendelse av dopamin-D3-reseptor-ligander for fremstilling av medikamenter for behandling av nyrefunksjonsforstyrrelser
MXPA04003087A (es) Derivados de cromano como ligados de 5-hidroxitriptamina-6.
MY124786A (en) Bis-arylsulfones
MXPA06000701A (es) Compuestos de sulfonildihidrobencimidazolona como ligandos de 5-hidroxitriptamina-6.
UA72948C2 (uk) Заміщені похідні фенілпіперазину, фармацевтична композиція та спосіб лікування афективних або неврологічних захворювань і розладів
GB9815618D0 (en) Treatment of dyskinesia
TW200607802A (en) 3-piperidinylisochroman-5-ols as dopamine agonists
PT730865E (pt) Utilizacao de bloqueadores dos receptores de serotonina e dopamina para o tratamento de perturbacoes mentais associadas a doencas cerebrovasculares
CY1107928T1 (el) Ενωσεις υποκατεστημενης αμινοκινουκλιδινης και χρησις των ως συνδεσμικα μεσα δελτα-οπιοειδους υποδοχεως
PT1642576E (pt) Utilização de derivados de pirrole para combate da ansiedade
GB9924941D0 (en) Treatment of dyskinesia
MXPA06000700A (es) Compuestos de sulfonildihidroimidazopiridinona como ligandos de 5-hidroxitriptamina-6.
TWI245756B (en) Improved process for the preparation of 1,3-substituted indenes
BR0308911A (pt) Composto, composição farmacêutica, métodos de tratamento de dor e de enxaqueca, e, uso de um composto
DE69907448D1 (de) Pyrido[2,3-b]indolizinderivate und aza analoge: crf1 spezifische liganden
HUP0303921A3 (en) Use of desoxypeganine for treating central nervous system symptoms resulting from intoxications by psychotrops